RankAlpha logo
Back to Rankings

ACXP

AcurxD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
ACXP vs peer average
56/100
ACXP vs. peer average (D vs. D)
Grade spread
B 1 · D 2 · F 5
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

APRE is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $8.69M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerAPREAprea Therapeutics
ACXP
Acurx
APRE
Aprea Therapeutics
Grade
D
D
Momentum
31
10
Value
58
57
Sentiment
-
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs APRE

ACXP / APRE
Grade Position
In line
ACXP vs. peer average (D vs. D)
56/100
Momentum
31
ACXP
Value
58
ACXP
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ACXP
1
APRE
Aprea Therapeutics Inc Common
D
40/100
Even
2
BIVI
BioVie Inc Class A Common
F
20/100
+1
3
EVGN
Evogene Ltd Common
F
20/100
+1
4
IMRN
Immuron Ltd ADR
F
20/100
+1
5
IMNN
Imunon Inc Common
B
80/100
-2
APRE is the first peer returned for this comparison set.